Halberd (Halberd) Long-Term Debt : $0.15 Mil (As of Jul. 2023)

View and export this data going back to 2009. Start your Free Trial

What is Halberd Long-Term Debt?

Halberd's Long-Term Debt for the quarter that ended in Jul. 2023 was $0.15 Mil.

Halberd's quarterly Long-Term Debt increased from Jul. 2008 ($0.00 Mil) to Jul. 2022 ($0.15 Mil) but then stayed the same from Jul. 2022 ($0.15 Mil) to Jul. 2023 ($0.15 Mil).

Halberd's annual Long-Term Debt increased from Jul. 2008 ($0.00 Mil) to Jul. 2022 ($0.15 Mil) but then stayed the same from Jul. 2022 ($0.15 Mil) to Jul. 2023 ($0.15 Mil).

Halberd Long-Term Debt Historical Data

The historical data trend for Halberd's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Halberd Long-Term Debt Chart

Halberd Annual Data

Trend

Jul08

Jul22

Jul23

Long-Term Debt

0.15

Halberd Semi-Annual Data
	Jul08	Jul22	Jul23
Long-Term Debt	-	0.15	0.15

Halberd (OTCPK:HALB) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Halberd Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Halberd's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Halberd (Halberd) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Halberd Corp (OTCPK:HALB) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

P.O. Box 25, Jackson Center, PA, USA, 16133

Website

https://www.halberdcorporation.com

Halberd Corp is a research-based biotechnology company seeking to discover and develop medical treatments for a range of diseases. The Company's extracorporeal treatment is designed to treat hard-to-cure blood-borne, neurologic and infectious diseases. The Company's patented methodology removes the appropriate bodily fluid from the patient, in a continuous fashion, like dialysis, or in a batch process, like blood sample testing.

Executives

John Christopher Maddox	director, 10 percent owner, officer: President, COO, Treasurer and, other: Interim CFO	10755 VERNON, HUNTINGTON WOODS MI 48070
Mark Sven Lundquist	director, 10 percent owner, officer: CEO, Secretary and Director	24655 TUDOR LANE, FRANKLIN MI 48025
Cocco Nicholas A. Jr.	director	50104 N. JIMMY COURT, CHESTERFIELD MI 48047-1898
Leland Michael Thomas	director	280 LASALLE PLACE, GROSSE POINTE FARMS MI 88236